Streetbeat News

Analyst Ratings

CE

JP Morgan analyst Jeffrey Zekauskas has upgraded Celanese (NYSE:CE) from Underweight to Neutral while lowering the price target from $156 to $130.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:46 am

JSPR

HC Wainwright & Co. analyst Emily Bodnar has reiterated a Buy rating on Jasper Therapeutics (NASDAQ:JSPR) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:45 am

ASO

JP Morgan analyst Christopher Horvers has downgraded Academy Sports (NASDAQ:ASO) from Overweight to Neutral and lowered the price target from $76 to $53.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:44 am

CBOE

JP Morgan analyst Kenneth Worthington has upgraded Cboe Global Markets (BATS:CBOE) from Underweight to Neutral and raised the price target from $168 to $195.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:42 am

ZVRA

HC Wainwright & Co. has maintained its Buy rating on Zevra Therapeutics (NASDAQ:ZVRA) and raised the price target from $15 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:41 am

PRAX

Oppenheimer has initiated coverage on Praxis Precision Medicine (NASDAQ:PRAX) with an Outperform rating and a price target of $134.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:39 am

FBIZ

DA Davidson analyst Kevin Reevey has upgraded First Business Financial Services (NASDAQ:FBIZ) from Neutral to Buy and raised the price target from $36 to $50.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:38 am

DKNG

Needham analyst Bernie McTernan reiterates a Buy rating on DraftKings (NASDAQ:DKNG) and maintains a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:36 am

DRH

Compass Point analyst Floris Van Dijkum has upgraded Diamondrock Hospitality (NYSE:DRH) from Neutral to Buy and set a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:34 am

MAG

HC Wainwright & Co. has maintained a Buy rating on MAG Silver and raised the price target from $17 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:34 am